According to the latest data from the Hong Kong Stock Exchange, on June 8th, Chairman and Chief Executive Officer Lou Jing increased his holdings in 3SBIO (HKEX: 01530) by 516,000 shares. The transaction price was HK$15.2497 per share, resulting in a total consideration of approximately HK$7.8688 million.

Following this acquisition, his total shareholding has risen to approximately 534 million shares, representing a 21.03% stake in the company. Additional information notes that Dr. Lou Jing is an enforcer and beneficiary of an unnamed discretionary trust.